Contains proteolytic enzymes enriched in bromelain [DR:D03162] obtained from pineapple stem juice
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
D03B ENZYMES
D03BA Proteolytic enzymes
D03BA03 Bromelains
D12495 Anacaulase <JP/US>
M MUSCULO-SKELETAL SYSTEM
M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
M09AB Enzymes
M09AB03 Bromelains
D12495 Anacaulase <JP/US>
USP drug classification [BR:br08302]
Dermatological Agents
Dermatological Agents, Other
Wound Care Agents
Anacaulase
D12495 Anacaulase
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
26 Epidermides
269 Miscellaneous
2699 Others
D12495 Anacaulase
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D12495
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12495
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D12495
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12495
